标题:Determination of domperidone in human plasma using liquid chromatography coupled to tandem mass spectrometry and its pharmacokinetic study.
作者:Zhang,D.;Chen,K.;Teng,Y.;Zhang,J.;Liu,S.;Wei,C.;Wang,B.;Liu,X.;Yuan,G.;Zhang,R.;Guo,R.
作者机构:[Zhang, D] Institute of Clinical Pharmacology, Qilu Hospital, Shandong University, 107 West Wenhua Road, 250012 Jinan, China;[ Chen, K] Institute of C 更多
通讯作者:Guo, R
通讯作者地址:[Guo, R]Shandong Univ, Qilu Hosp, Inst Clin Pharmacol, 107 W Wenhua Rd, Jinan 250012, Peoples R China.
来源:Arzneimittel-Forschung: =Drug Research
出版年:2012
卷:62
期:3
页码:128-133
DOI:10.1055/s-0031-1298010
关键词:domperidone; LC-MS/MS; pharmacokinetics; paracetamol
摘要:A sensitive and selective liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the quantification of domperidone (CAS number: 57808-66-9) in human plasma using paracetamol (CAS number: 103-90-2) as an internal standard (IS). Domperidone and paracetamol in plasma were extracted with ethyl acetate, separated on a C18 reversed phase column, eluted with mobile phase of acetonitrile-glacial acetic acid (0.3%) (40:60, v/v), ionized by positive ion pneumatically assisted electrospray and detected in the multi-reaction monitoring mode using precursor→product ions of m/z 426.2→175.1 for domperidone and 152→110 for the IS, respectively. The calibration curve was linear (r2≥0.99, n=5) over the concentration range of 0.2-80 ng/mL and with lower limit of detection and quantitation of 0.05 and 0.2 ng/mL. The specificity, matrix effect, recovery, sensitivity, linearity, accuracy, precision, and stabilities were validated for domperidone in human plasma. In conclusion, the validation results showed that this method was sensitive, economical and less toxic and it can successfully fulfill the requirement of clinical pharmacokinetic study of domperidone oral preparation in Chinese healthy volunteers.
收录类别:SCOPUS;SCIE
WOS核心被引频次:5
Scopus被引频次:6
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860611007&doi=10.1055%2fs-0031-1298010&partnerID=40&md5=d49045c847ff622be3b6b5bac33b77f2
TOP